Liver Cirrhosis Clinical Trials

73 recruitingLast updated: June 17, 2026

There are 73 actively recruiting liver cirrhosis clinical trials across 33 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4. Top locations include New Delhi, National Capital Territory of Delhi, India, London, United Kingdom, Vienna, Austria. Updated daily from ClinicalTrials.gov.


Liver Cirrhosis Trials at a Glance

73 actively recruiting trials for liver cirrhosis are listed on ClinicalTrialsFinder across 6 cities in 33 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in New Delhi, London, and Vienna. Lead sponsors running liver cirrhosis studies include Institute of Liver and Biliary Sciences, India, European Foundation for Study of Chronic Liver Failure, and Medical University of Vienna.

Browse liver cirrhosis trials by phase

Treatments under study

About Liver Cirrhosis Clinical Trials

Looking for clinical trials for Liver Cirrhosis? There are currently 68 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Liver Cirrhosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Liver Cirrhosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 73 trials

Recruiting
Phase 2

A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

Liver Cirrhosis
Boehringer Ingelheim29 enrolled27 locationsNCT07325526
Recruiting
Not Applicable

Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis

Liver CirrhosisGastroesophageal Varices Bleeding
Air Force Military Medical University, China648 enrolled1 locationNCT07253389
Recruiting
Not Applicable

Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.

Decompensated Liver Cirrhosis
Institute of Liver and Biliary Sciences, India60 enrolled1 locationNCT07002827
Recruiting

Austrian PBC Registry

Liver CirrhosisPrimary Biliary CholangitisPortal Hypertension
Medical University of Vienna500 enrolled11 locationsNCT07598669
Recruiting

Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

Liver CirrhosisLiver TransplantationAcute Liver Failure+1 more
University Medical Center Groningen10,000 enrolled2 locationsNCT07585890
Recruiting
Not Applicable

The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis

Liver CirrhosisEsophageal and Gastric Varices
The First Hospital of Jilin University380 enrolled1 locationNCT07151885
Recruiting

Freiburg TIPS Registry

Liver CirrhosisPortal Vein ThrombosisPortal Hypertension+3 more
University Hospital Freiburg2,000 enrolled1 locationNCT05782556
Recruiting
Not Applicable

Early TIPS in Patients With Liver Cirrhosis and Ascites

Liver CirrhosisPortal HypertensionAscites Hepatic
University Hospital Freiburg134 enrolled1 locationNCT06576934
Recruiting
Not Applicable

Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation

SarcopeniaLiver CirrhosisFrailty+3 more
Kalliopi Anna Poulia90 enrolled2 locationsNCT07561138
Recruiting

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

Liver CirrhosisPortal Hypertension
Assistance Publique - Hôpitaux de Paris45 enrolled1 locationNCT07439939
Recruiting

Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal Bleeding

Gastrointestinal BleedingLiver Cirrhosis
St. Martin De Porress Hospital150 enrolled1 locationNCT06680583
Recruiting
Not Applicable

Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing Invasive Procedures

Liver Cirrhosis With Acute Decompensation
Grigore T. Popa University of Medicine and Pharmacy116 enrolled1 locationNCT07437755
Recruiting
Phase 1

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Liver Cirrhosis
Insel Gruppe AG, University Hospital Bern24 enrolled1 locationNCT04874428
Recruiting
Phase 2

Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis

CirrhosisDecompensated Cirrhosis of LiverDecompensated Liver Cirrhosis+1 more
CAMC Health System50 enrolled1 locationNCT06764966
Recruiting
Phase 3

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Liver Cirrhosis
King's College London300 enrolled23 locationsNCT06461208
Recruiting

The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)

Cognitive DysfunctionLiver CirrhosisNeurocognitive Disorders+1 more
University of Malaya230 enrolled1 locationNCT07418008
Recruiting
Phase 1Phase 2

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

Liver DiseasesCirrhosis, LiverDecompensated Liver Cirrhosis+5 more
Resolution Therapeutics Limited30 enrolled14 locationsNCT06823713
Recruiting
Not Applicable

Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients

Gastrointestinal dysfunctionLiver CirrhosisPolyps of Colon
Zhejiang University450 enrolled3 locationsNCT07252102
Recruiting
Not Applicable

Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

Liver CirrhosisPortal Hypertension
Shanxi Provincial People's Hospital120 enrolled2 locationsNCT07116096
Recruiting
Not Applicable

Underdilated-stent Technique Improves Post-TIPS Encephalopathy

Liver CirrhosisAscites HepaticVariceal Bleeding, Cirrhosis+1 more
The Second Affiliated Hospital of Chongqing Medical University72 enrolled2 locationsNCT07349654